drugset / Trial / NCT00823225
Urokinase Therapy in Patients With Diabetic Foot Syndrome
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the additional therapy with low dose urokinase is more effective than only a conventional standard therapy concerning ulcer-healing, rate of major amputation and survival.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-06
- Completion
- 2009-06
Outcome
Outcome not reported
Stopped (Enrollment): “Insufficient recruitment of study patients”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Urokinase | Protein / enzyme biologic | 500000 iu | — |
| Subject | Urokinase | Protein / enzyme biologic | 1e+06 iu | — |